COVID-19 Yorkshire Rehabilitation Scale

A award-winning digital assessment and monitoring tool to help remotely manage individuals with persistent COVID symptoms. A not for profit initiative for all NHS organisations.

  • Recommended by NHS England
  • Funded by the NIHR
  • Developed with NHS Trusts
  • Used by the NHS across the UK
  • Clinical validated for Long Covid patients
  • Independently validated for assurance on clinical safety and information governance
  • Contains other established outcome measures

For more information contact: c19-yrs@elaros.com

Find out how the C19-YRS can support your organisation

As Featured on BBC North West and 
ITV News Online

BBC North West recently featured the C19-YRS app on the 3rd September 2021 as part of an early implementation case study demonstrating its successful rollout at the Northern Care Alliance NHS Group.

The full news story can be read online on ITV News here.

Recommended by NHS England

NHS England has recommended routine use of C19-YRS at first assessment, 6 weeks and 6 months to monitor Long COVID in their National Guidance published in December 2020 and April 2021. The tool has also been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19.

Created by clinical academics, supported by the NIHR

C19-YRS is a clinically validated outcome measure developed by clinical academics at The University of Leeds during the first wave of the pandemic. Its ongoing development and optimisation for delivery has been funded by the National Institute for Health Research.

Developed with NHS Trusts

Developed by clinicians across Leeds, Hull, and Airedale, with support from clinicians around the UK.

Supported by our first adopters in Salford Royal, Pennine Acute, and Liverpool University Hospitals NHS Trusts.

Enhanced by UK industry experts

Digitally enhanced by ELAROS 24/7 Ltd, building on their established CE-marked medical device, the Digital Bladder Diary platform. This project has been supported by Innovate UK.

Validation for clinical assurance

The digital C19-YRS has been independently validated by ORCHA as being compliant with national standards for usability, clinical safety, and information governance.

ELAROS has also met all standards for the NHS DSPT and obtained the CyberEssentials certification, demonstrating good practice in data security and protection.

Award winning system developed by an award-winning consortium

ELAROS and The University of Leeds won Medipex’s 2021 Innovation Awards in its ‘Management of Long Term Conditions’ category for the development of the digital C19-YRS, alongside Leeds Community Healthcare and Leeds Teaching Hospitals NHS Trust for their design and implementation of the first long covid rehabilitation service.

Separately, Leeds Community Healthcare and Leeds Teaching Hospitals won the 2021 BMJ Awards for the ‘Clinical Leadership Team of the Year’, for the development of the UK’s first long covid rehabilitation service, which is considered a benchmark for the country.

Our Supporters

The digital C19-YRS has been developed by UK-based digital health company, ELAROS 24/7 Ltd, working closely with clinical researchers at The University of Leeds who developed the original self-report and provided initial funding to initiate the digital development with ELAROS’ third-party strategic partner software development company, Pipe & Piper in order to rapidly develop the platform to an industrial, clinically safe and secure standard. The scale was developed by clinicians at Leeds Teaching Hospitals Trust, Leeds Community Healthcare NHS Trust, and Airedale and Hull NHS Trusts.

It has been recommended for routine use by NHS England, funded by the NIHR, recognised by NICE, published in the ACNR, and endorsed by the British Society for Rehabilitation Medicine.

Benefits

For clinicians

For patients

For research